You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞銀窩輪》科技股股價整體回升 兩手準備美團認購26423、阿里認購17784
港股周二微高開,升近百點後恆指回落至22650-22700點水平,午後各板塊都積極反彈,帶動恆指走勢拉升,跌幅一直收窄,最終全日倒升48點,收報22761點。 美團(3690)經過較早前外賣平台需要下調服務費標準一事,加上外圍局勢緊張等因素,美團股價一直受壓,上周四更收於低位170.2港元;至於騰訊(0700)亦如美團一樣,上周四、五股價下跌至約425港元水平。美團、騰訊持續表現偏弱,周二可見股價開始回升,騰訊甚至有較顯著升幅,周二騰訊升2.3%,收報431港元;美團升0.7%,收報173.4港元。至於另一重磅科技股阿里(9988)上周四公佈業績,截至去年底止的財政年度第三季純利按年下跌75%,經調整利潤按年亦下跌25%;收入方面則按年上升約10%,整體收入增長放緩。阿里業績公佈後,阿里上周五股價有微升幅,但周一及周二阿里連跌兩個交易日,最新續跌0.4%,收報103.8港元,再創上市新低。由於近日科技股整體表現波動,根據瑞銀周二資金流,沒有引伸波幅影響的牛熊證明顯有較以往多的資金部署,尤其是美團及阿里;隨著科技股股價回升,相關認股證的引伸波幅亦有機會回落。如投資者看好科技股股價可以重新展開升勢,看好美團可留意美團認購26423,行使價230.2港元,22年7月到期,有效槓桿約5.9倍。如投資者看好騰訊,可留意騰訊認購19366,行使價500.631港元,22年5月到期,有效槓桿約10倍。如投資者看好阿里,可留意阿里認購17784,行使價130.4港元,22年7月到期,有效槓桿約5.5倍。 另外,香港第五波疫情日趨嚴重,每日確診數字飆升,周一上午港府表示不排除全民檢測期間會推行禁足令,市場更一度憂慮會有停市的可能性,截至周二,證監會明確表示即使政府在推行全民檢測期間限制人流,仍然有信心持牌機構及市場可以如常運作。證監會的回應或希望消除市場的憂慮,惟計劃推行禁足令的消息令港交所(0388)周一股價曾跌至低位372.8港元,周二港交所股價續跌0.4%,收報376港元,相比約一周前的股價(上周一收於430.8港元)大幅下跌逾12%,亦創近一年以來新低。根據瑞銀周二記錄,留意到港交所的相關認購證或牛證明顯較平日多的資金支持,如希望博港交所股價反彈的可留意新上市的港交認購27714,行使價455.88港元,22年9月到期。如希望一牛證作部署的投資者,看好港交所可留意新上市的港交牛證68340,收回價350港元,行使價348港元,22年11月到期。 更多窩輪牛熊資訊:瑞銀認股證牛熊證網站:http://www.ubs.com/hkwarrants 窩證教學及巿焦點況短片: https://www.youtube.com/channel/UCKw86qy4eBAInmd52MND45Q?view_as=subscriber 謝宛彤 瑞銀亞洲股票衍生產品銷售部 本產品並無抵押品。 如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。筆者為UBS AG的代表(作為證監會持牌人),並未持有相關上市公司的任何財務權益。本資料由瑞銀刊發,其並不構成買賣建議、邀請、要約或遊說。結構性產品價格可急升或急跌,投資者可能會蒙受全盤損失。過往表現並不反映將來表現。牛熊證備強制贖回機制而可能被提早終止,屆時 (i) N類牛熊證投資者將不獲發任何金額;而(ii) R類牛熊證之剩餘價值可能為零。投資前應瞭解有關風險,並諮詢專業顧問及查閱有關上市檔。UBS Securities Hong Kong Limited為結構性產品之流通量提供者,亦可能是唯一報價者或巿場參與者。(C) UBS 2022。版權所有。~ 重要聲明: 以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account